Detalhe da pesquisa
1.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 606(7915): 797-803, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705814
2.
Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumab.
Gynecol Oncol
; 180: 139-145, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38091773
3.
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 613(7945): E3, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627494
4.
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort.
Am J Obstet Gynecol
; 224(3): 278.e1-278.e14, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32835719
5.
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Am J Obstet Gynecol
; 224(2): 191.e1-191.e15, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32805208
6.
Improving response to progestin treatment of low-grade endometrial cancer.
Int J Gynecol Cancer
; 30(11): 1811-1823, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381512
7.
Bringing Cancer Prevention Research Competencies to the Classroom.
J Cancer Educ
; 33(1): 109-115, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325275
8.
Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.
Oncology
; 92(2): 109-114, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27931017
9.
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
Int J Gynecol Cancer
; 27(5): 854-862, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28498246
10.
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.
Gynecol Oncol
; 133(1): 83-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24680596
11.
Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses.
Cancers (Basel)
; 16(5)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473208
12.
Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.
Cancer
; 119(16): 3027-33, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23760948
13.
Chemopreventive effects of metformin on obesity-associated endometrial proliferation.
Am J Obstet Gynecol
; 209(1): 24.e1-24.e12, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23500454
14.
TIME for Bugs: The Immune Microenvironment and Microbes in Precancer.
Cancer Prev Res (Phila)
; 16(9): 497-505, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428011
15.
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
Proc Natl Acad Sci U S A
; 106(1): 250-5, 2009 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-19104057
16.
Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
Cancers (Basel)
; 13(5)2021 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668244
17.
Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications.
J Control Release
; 339: 521-530, 2021 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648891
18.
The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice.
Am J Respir Crit Care Med
; 180(9): 867-74, 2009 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19679692
19.
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study.
Clin Cancer Res
; 26(3): 581-587, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628143
20.
Fertility-sparing treatment in early endometrial cancer: current state and future strategies.
Obstet Gynecol Sci
; 63(4): 417-431, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32689770